Q-Develop

Q-develop is a Dutch biotechnology company specializing in the development of advanced dry powder inhalation (DPI) technologies and formulations. The company's core expertise lies in the design of the proprietary Cyclops inhaler platform, a high-dose, disposable device capable of delivering large quantities of medication directly to the lungs with high efficiency. Q-develop focuses on transforming existing drugs into inhaled formats to improve efficacy, reduce systemic side effects, and provide rapid onset of action for both respiratory and systemic conditions. Their pipeline includes inhaled versions of antibiotics for cystic fibrosis and tuberculosis, as well as therapies for Parkinson's disease. The company operates as a technology developer and R&D engine, often collaborating with its commercial partner PureIMS and academic institutions like the University of Groningen.